Michael Kaback

Michael Kaback

Michael M. Kaback, M.D. is a Professor of Pediatrics and Reproductive Medicine, and chief of the Division of Medical Genetics, at the University of California-San Diego.

He is best known for his role in the discovery and development of an enzyme assay method of screening for Tay-Sachs disease, a rare and fatal genetic disorder. This test allowed for cost-effective screening of large populations, the first such test in medical genetics. Because no large scale genetic screening had ever been done before, Kaback became involved in public health aspects of screening, including the education of target populations and genetic counseling. Although no cure for Tay-Sachs disease has been found, antenatal genetic screening has virtually eliminated the disease in the Ashkenazi Jewish population in both the United States and Israel.

In 1979, Kaback served on the first National Institutes of Health (NIH) panel to recommend antenatal diagnosis in cases where a couple might be at risk for conceiving a child with a hereditary disease or congenital defect. The panel brought together physicians, scientists, consumers, and others in order to develop a consensus statement for use by health care providers. In the NIH Consensus Development Program, panel members are selected for their expertise to serve as judges of evidence, and must have no prior conflicts of interest. Panel members addressed issues concerning the relative risks and benefits of genetic screening, including the costs and risks of the screening procedures themselves.[1] It was the first NIH panel to provide recommendations for genetic screening, and its findings have since been revised many times.

Kaback's brother, H. Ronald Kaback, UCLA, pioneered purification of intact E. coli membranes and used them in assays to measure chemiosmotic potential in membranes, an important contribution to Peter Mitchell's theory. Since then Kaback has gone on to purify and characterize lactose permease, the enzyme responsible for lactose transport across E. coli membranes.

See also

References

  1. ^ "Antenatal Diagnosis". National Institutes of Health, Consensus Development Program. 1979. http://consensus.nih.gov/1979/1979AntenatalDx012html.htm. 

Selected publications

  • Robert J. Desnick and Michael M. Kaback (editors). Tay Sachs Disease. Academic Press, 2001. ISBN 0120176440.
  • Kaback, Michael M. (2001). "The 'Asilomar Process' and the Human Genome Project"

Perspectives in Biology and Medicine Vol 44:2. Johns Hopkins University Press. pp. 230–234.

  • Kaback, Michael M. (1993) et al. "Tay Sachs Disease — Carrier Screening, Prenatal Diagnosis, and the Molecular Era: An International Perspective, 1970 to 1993." Journal of the American Medical Association Vol 270:19 pp. 2307–2315.



Wikimedia Foundation. 2010.

Игры ⚽ Нужна курсовая?

Look at other dictionaries:

  • Tay-Sachs disease — Infobox Disease Name = Tay Sachs disease Caption = DiseasesDB = 12916 ICD10 = ICD10|E|75|0|e|70 ICD9 = ICD9|330.1 ICDO = OMIM = 272800 OMIM mult = OMIM2|272750 MedlinePlus = 001417 eMedicineSubj = ped eMedicineTopic = 3016 MeshID = D013661 Tay… …   Wikipedia

  • Mayana Zatz — Mayana Zata en 2010. Nacimiento 16 de julio de 1947 (64 años) Tel Aviv, Israel …   Wikipedia Español

  • Retard mental — Classification et ressources externes CIM 10 F70. F79. CIM 9 317 …   Wikipédia en Français

  • Rosenstiel Award — Der Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research ist ein von Lewis Solon Rosenstiel gestifteter Wissenschaftspreis, der die medizinische Grundlagenforschung fördern soll. Er wird jährlich von der Brandeis University… …   Deutsch Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”